Who is sponsoring NCT03698526?

NCT03698526 is sponsored by University Hospital Muenster.

What drugs are being tested in NCT03698526?

Interventions in NCT03698526: Samsung Gear VR, Galaxy S8, Applied VR App.

What condition does NCT03698526 study?

NCT03698526 studies Palliative Care, Virtual Reality, Pain.

Is NCT03698526 still recruiting?

NCT03698526 is currently status unknown. Last updated 10 October 2018.

Last reviewed 2018-10-10 · How we verify

NCT03698526: VRPC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality for Symptoms Control in Palliative Care

Status unknown NA Last updated 10 October 2018

What this trial tests

NA trial testing Samsung Gear VR, Galaxy S8, Applied VR App in Palliative Care in 180 participants. Status unknown.

Timeline

1 September 2018

Primary endpoint
30 September 2019

15 December 2019

Quick facts

Lead sponsor	University Hospital Muenster
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	supportive care
Enrollment	180
Start date	1 September 2018
Primary completion	30 September 2019
Estimated completion	15 December 2019
Sites	2 locations across Germany

Drugs / interventions tested

Samsung Gear VR, Galaxy S8, Applied VR App

Conditions studied

Palliative Care — all drugs for Palliative Care →
Virtual Reality — all drugs for Virtual Reality →
Pain — all drugs for Pain →

Sponsor

University Hospital Muenster

Who can join

Adults 18 to 99, any sex, with Palliative Care or Virtual Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate how Virtual Reality (VR) can be used to control symptoms and improve the quality of life in palliative care. The interventional prospective case control study is planned to contain five phases including two control groups. The following describes only phase one to three. In the pilot phase patients get a one-time application of the VR-Technology. After that, two control groups will be recruited from patients with 1. mamma carcinoma and the indication of (neo-) adjuvant radiotherapy and 2. before a colonoscopy-treatment. Both groups receive the VR application before treatment (radiotherapy/colonoscopy). This first part proofs the application of Virtual Reality on patients in palliative care with the aim to control symptoms and reduce pain and anxiety. The clinical study hypothesis bases on the assumption that VR reduces pain and anxiety and may have a positive influence on their quality of life.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Virtual reality reduces pain in palliative care-A feasibility trial.
Guenther M, Görlich D, Bernhardt F, Pogatzki-Zahn E, et al · · 2022 · cited 20× · PMID 36195865 · DOI 10.1186/s12904-022-01058-4
Virtual Reality improves symptom control in palliative care – a feasibility trial
Guenther M, Görlich D, Pogatzki-Zahn E, Dasch B, et al · · 2022 · cited 1× · DOI 10.21203/rs.3.rs-1463275/v1

Verify or expand the search:

Other recruiting trials for Palliative Care

Currently open trials in the same condition.

NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting
NCT07469761 — MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care · NA · recruiting
NCT06588556 — Improving Needs Among Older Adults · NA · recruiting
NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
NCT06771999 — Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Phar · NA · recruiting

Other University Hospital Muenster trials

Trials by the same sponsor.

NCT07414498 — MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery · NA · not yet recruiting
NCT06999174 — Multiparametric MRI for Characterization of Hepatocellular Carcinoma · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting
NCT06648733 — Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care · NA · recruiting
NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03698526 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Muenster
Last refreshed: 10 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03698526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing